In the PB, ALE, IDH-WT glioma, and CNS-DLBCL patients shared an increase in activated CD8+ and CD4+ Tc, however, Tc activation was even more pronounced in IDH-WT glioma and CNS-DLBCL than in ALE. The gene discussed is CD8A; the disease is central nervous system cancer.